TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)

Effect of Long-term Remodulin Therapy on the 6-Minute Walk Distance (6MWD)

The intent of the 6-Minute Walk Test (6MWT) is to evaluate exercise capacity associated with carrying out activities of daily living.

Time frame: The 6MWD was assessed at each subject's last visit, which occurred up to approximately 9 years after first visit

Effect of Long-term Remodulin Therapy on the NYHA Functional Classification

The NYHA functional classification ranges from I (subject's disease does not affect daily activities) to IV (subject's disease causes severe impairment).

Time frame: The NYHA functional classification was assessed at each subject's last visit, which occurred up to approximately 9 years after first visit

Effect of Long-term Remodulin Therapy on Subject Safety

Safety was assessed by summarizing the number of subjects with at least 1 AE during the 12 weeks (or until premature termination).

Time frame: Baseline to Week 12